K. Wong

Treatment of ulcerative colitis with adalimumab or infliximab: long‐term follow‐up of a single‐centre cohort

R. Fedorak, K. Kroeker, N. Gies, 2010, Alimentary pharmacology & therapeutics.

Double blind placebo-controlled trial for the prevention of ulcerative colitis relapses by β-fructan prebiotics: efficacy and metabolomic analysis

D. Kao, L. Dieleman, S. V. van Zanten, 2022, medRxiv.

Postprandial hypergastrinaemia in patients with colorectal cancer.

G. Poston, J. Calam, K. Beardshall, 1991, Gut.

Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort

G. Kaplan, S. Devlin, R. Panaccione, 2017, Alimentary pharmacology & therapeutics.

A146 THE EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN PATIENTS WITH ULCERATIVE COLITIS

L. Dieleman, K. Kroeker, F. Peerani, 2022, Journal of the Canadian Association of Gastroenterology.